City
BEST EMS
BEST EMS (Southlake, TX) carries 41 drugs across 190 dose entries in its current published protocol, effective 2026-01-01.
Drugs and doses41
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | See protocols | PO | not captured | standing | page 198 |
| Fever | adult | See protocols | IV | not captured | standing | page 198 |
| Mild to moderate pain | adult | See protocols | PO | not captured | standing | page 198 |
| Mild to moderate pain | adult | See protocols | IV | not captured | standing | page 198 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | See protocols | IV | not captured | standing | page 141 |
| Narrow-complex tachycardia | adult | See protocols | IO | not captured | standing | page 141 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg (max 12 mg) | IV | not captured | standing | page 141 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg (max 12 mg) | IO | not captured | standing | page 141 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5–7.5 mg | NEB | not captured | standing | page 35 |
| Asthma / bronchospasm | peds | 2.5–7.5 mg | NEB | not captured | standing | page 35 |
| Hyperkalemia | adult | 2.5–7.5 mg | NEB | not captured | standing | page 59 |
| Hyperkalemia | peds | 2.5–7.5 mg | NEB | not captured | standing | page 59 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV | not captured | standing | page 45 |
| Other | adult | 300 mg | IO | not captured | standing | page 45 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 45 |
| Other | peds | 5 mg/kg | IO | not captured | standing | page 45 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 49 |
| Stroke | adult | 325 mg | PO | not captured | standing | page 200 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 40 |
| Bradycardia | adult | 1 mg | IO | not captured | standing | page 40 |
| Bradycardia | peds | 0.02 mg/kg (max 1 mg) | IV | not captured | standing | page 40 |
| Bradycardia | peds | 0.02 mg/kg (max 1 mg) | IO | not captured | standing | page 40 |
| Organophosphate poisoning | adult | 3 mg | IV | not captured | standing | page 75 |
| Organophosphate poisoning | adult | 3 mg | IO | not captured | standing | page 75 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV | not captured | standing | page 75 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IO | not captured | standing | page 75 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 44 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 44 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 44 |
| Hyperkalemia | peds | 60 mg/kg | IV/IO | not captured | standing | page 44 |
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 87 |
| Trauma / hemorrhage | peds | 60 mg/kg | IV/IO | not captured | standing | page 87 |
Cefepime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 2 g | IV/IO | not captured | standing | page 86 |
| Sepsis | peds | 50 mg/kg | IV/IO | not captured | standing | page 86 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 86 |
| Trauma / hemorrhage | peds | 50 mg/kg | IV/IO | not captured | standing | page 86 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 35 |
| Allergic reaction | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 35 |
| Asthma / bronchospasm | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 81 |
| Asthma / bronchospasm | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 81 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 81 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 81 |
| COPD | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 81 |
| COPD | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 81 |
| Other | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 201 |
| Other | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 201 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mL | IV/IO | not captured | standing | page 54 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 54 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10–20 mg | IV/IO | not captured | standing | page 95 |
| Atrial fibrillation with RVR | adult | 10–20 mg | IV/IO | not captured | standing | page 95 |
| Narrow-complex tachycardia | adult | 10–20 mg | IV/IO | not captured | standing | page 95 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | page 35 |
| Allergic reaction | adult | 50 mg | IV/IO/IM/PO | not captured | standing | page 35 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 35 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM/PO | not captured | standing | page 35 |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | page 36 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 36 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 63 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 63 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | IV/IO/IM | not captured | standing | page 80 |
| Nausea / vomiting | adult | 1.25–2.5 mg | IV/IO/IM | not captured | standing | page 64 |
| Other | adult | 1.25–2.5 mg | IV/IO/IM | not captured | standing | page 63 |
| Mild to moderate pain | adult | 1.25–2.5 mg | IV/IO/IM | not captured | standing | page 78 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 36 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 36 |
| Asthma / bronchospasm | adult | 0.5 mg | IM | not captured | standing | page 129 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 129 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 45 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 45 |
| Hypotension / shock | adult | 10–20 mcg | IV/IO | not captured | standing | page 33 |
| Hypotension / shock | peds | 10 mcg | IV/IO | not captured | standing | page 33 |
| Stridor | adult | 5 mL | NEB | not captured | standing | page 36 |
| Stridor | peds | 5 mL | NEB | not captured | standing | page 36 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 92 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 92 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 187 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 187 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO | not captured | standing | page 50 |
| Mild to moderate pain | adult | 1 mcg/kg | IM | not captured | standing | page 77 |
| Mild to moderate pain | adult | 2 mcg/kg | IN | not captured | standing | page 77 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO | not captured | standing | page 50 |
| Mild to moderate pain | peds | 1 mcg/kg | IM | not captured | standing | page 77 |
| Mild to moderate pain | peds | 2 mcg/kg | IN | not captured | standing | page 77 |
| Post-intubation sedation | adult | 1–2 mcg/kg | IV/IO | not captured | standing | page 189 |
| Post-intubation sedation | peds | 1–2 mcg/kg | IV/IO | not captured | standing | page 189 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 41 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | page 41 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500–1500 mcg | NEB | not captured | standing | page 35 |
| Asthma / bronchospasm | peds | 500–1500 mcg | NEB | not captured | standing | page 35 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO/IN | not captured | standing | page 80 |
| Agitation | adult | 2–4 mg/kg | IM | not captured | standing | page 80 |
| Agitation | peds | 1 mg/kg | IV/IO/IN | not captured | standing | page 80 |
| Agitation | peds | 2–4 mg/kg | IM | not captured | standing | page 80 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 44 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 44 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO/IN | not captured | standing | page 77 |
| Mild to moderate pain | adult | 0.3 mg/kg | IM | not captured | standing | page 77 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO/IN | not captured | standing | page 77 |
| Mild to moderate pain | peds | 0.3 mg/kg | IM | not captured | standing | page 77 |
| Post-intubation sedation | adult | 1 mg/kg | IV/IO | not captured | standing | page 189 |
| Post-intubation sedation | peds | 1 mg/kg | IV/IO | not captured | standing | page 189 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 187 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 187 |
| Seizure | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 83 |
| Seizure | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 83 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 20 mg | IV/IO | not captured | standing | page 66 |
| Other | adult | 10–20 mg | IV/IO | not captured | standing | page 60 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mL | IO | not captured | standing | page 173 |
| Other | peds | 0.5 mg/kg (max 40 mg) | IO | not captured | standing | page 173 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | peds | 50 mg/kg (max 2 g) | IV/IO | not captured | standing | page 129 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 66 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 45 |
| Other | peds | 50 mg/kg (max 2 g) | IV/IO | not captured | standing | page 45 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 45 |
| VF / pulseless VT | peds | 50 mg/kg (max 2 g) | IV/IO | not captured | standing | page 45 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 32 |
| Adrenal crisis | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | page 32 |
| Allergic reaction | adult | 125 mg | IV/IO/IM | not captured | standing | page 35 |
| Allergic reaction | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | page 35 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | page 81 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | page 81 |
| Asthma / bronchospasm | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | page 81 |
| Asthma / bronchospasm | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | page 81 |
| COPD | adult | 125 mg | IV/IO/IM | not captured | standing | page 81 |
| COPD | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | page 81 |
| Other | adult | 125 mg | IV/IO/IM | not captured | standing | page 81 |
| Other | peds | 2 mg/kg (max 100 mg) | IV/IO/IM | not captured | standing | page 81 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 10 mg | IV/IO/IM | not captured | standing | page 63 |
| Nausea / vomiting | adult | 10 mg | IV/IO/IM | not captured | standing | page 63 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 63 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 63 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 2.5–5 mg | IV/IO | not captured | standing | page 95 |
| Atrial fibrillation with RVR | adult | 2.5–5 mg | IV/IO | not captured | standing | page 95 |
| Narrow-complex tachycardia | adult | 2.5–5 mg | IV/IO | not captured | standing | page 95 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | page 80 |
| Agitation | adult | 2.5–5 mg | IM | not captured | standing | page 80 |
| Agitation | peds | 0.05 mg/kg (max 2.5 mg) | IV/IO/IN | not captured | standing | page 39 |
| Agitation | peds | 0.05 mg/kg (max 2.5 mg) | IM | not captured | standing | page 39 |
| Agitation | peds | 0.1 mg/kg (max 5 mg) | IV/IO/IN | not captured | standing | page 80 |
| Agitation | peds | 0.1 mg/kg (max 5 mg) | IM | not captured | standing | page 80 |
| Eclampsia / pre-eclampsia | adult | 10 mg | IM | not captured | standing | page 67 |
| Eclampsia / pre-eclampsia | adult | 5 mg | IV/IO/IN | not captured | standing | page 67 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 83 |
| Seizure | adult | 5 mg | IV/IO/IN | not captured | standing | page 83 |
| Seizure | peds | 0.2 mg/kg (max 10 mg) | IM | not captured | standing | page 83 |
| Seizure | peds | 0.2 mg/kg (max 5 mg) | IV/IO/IN | not captured | standing | page 83 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–4 mg | IV/IO | not captured | standing | page 50 |
| Mild to moderate pain | adult | 2–4 mg | IM | not captured | standing | page 50 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 50 |
| Mild to moderate pain | peds | 0.1 mg/kg | IM | not captured | standing | page 50 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM/IN/NEB | not captured | standing | page 38 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN/NEB | not captured | standing | page 38 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 49 |
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 49 |
| CHF / pulmonary edema | adult | 0.8 mg | SL | not captured | standing | page 52 |
| CHF / pulmonary edema | adult | 1 mg | IV/IO | not captured | standing | page 52 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4–30 mcg | IV/IO | not captured | standing | page 33 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/IN/PO | not captured | standing | page 64 |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/IN/PO | not captured | standing | page 64 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN/PO | not captured | standing | page 64 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN/PO | not captured | standing | page 64 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | One tube | PO | not captured | standing | page 54 |
| Hypoglycemia | peds | One tube | PO | not captured | standing | page 54 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mL | NEB | not captured | standing | page 56 |
| Other | peds | 1 mL | NEB | not captured | standing | page 56 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | not captured | not captured | standing | page 74 |
| Other | peds | 1–2 drop | not captured | not captured | standing | page 74 |
| Mild to moderate pain | adult | 1–2 drop | not captured | not captured | standing | page 74 |
| Mild to moderate pain | peds | 1–2 drop | not captured | not captured | standing | page 74 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 44 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 44 |
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 187 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 187 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 44 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 44 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 44 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 44 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 44 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 44 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25 mg | SQ | not captured | standing | page 82 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | SQ | not captured | standing | page 82 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 g | IV/IO | not captured | standing | page 37 |
| Other | adult | 500 mg | not captured | not captured | standing | page 56 |
| Other | peds | 500 mg | not captured | not captured | standing | page 56 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 158 |
| Trauma / hemorrhage | adult | 500 mg | NEB | not captured | standing | page 56 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 158 |
| Trauma / hemorrhage | peds | 500 mg | NEB | not captured | standing | page 56 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 187 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 187 |